Therapeutic efficacy of proton transport inhibitors alone or in combination with cisplatin in triple negative and hormone sensitive breast cancer models

Triple negative breast cancers (TNBCs) are very aggressive and have a poor prognosis due to lack of efficacious therapies. The only effective treatment is chemotherapy that however is frequently hindered by the occurrence of drug resistance. We approached this problem in vitro and in vivo on a tripl...

Descripción completa

Detalles Bibliográficos
Autores principales: Balza, Enrica, Carlone, Sebastiano, Carta, Sonia, Piccioli, Patrizia, Cossu, Vanessa, Marini, Cecilia, Sambuceti, Gianmario, Rubartelli, Anna, Castellani, Patrizia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8704177/
https://www.ncbi.nlm.nih.gov/pubmed/34796694
http://dx.doi.org/10.1002/cam4.4371

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8704177/
https://www.ncbi.nlm.nih.gov/pubmed/34796694
http://dx.doi.org/10.1002/cam4.4371

Ejemplares similares